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North American Indian childhood cirrhosis (NAIC, or CIRH1A) is an isolated nonsyndromic form of familial
cholestasis reported in Ojibway-Cree children and young adults in northwesternQuebec. The pattern of transmission
is consistent with an autosomal recessive mode of inheritance. To map the NAIC locus, we performed a genomewide
scan on three DNA pools of samples from 13 patients, 16 unaffected siblings, and 22 parents from five families.
Analysis of 333 highly polymorphic markers revealed 3 markers with apparent excess allele sharing among affected
individuals. Additional mapping identified a chromosome 16q segment shared by all affected individuals. When
the program FASTLINK/LINKAGE was used and a completely penetrant autosomal recessive mode of inheritance
was assumed, a maximum LOD score of 4.44 was observed for a recombination fraction of 0, with marker
D16S3067. A five-marker haplotype (D16S3067, D16S752, D16S2624, D16S3025, and D16S3106) spanning 4.9
cM was shared by all patients. These results provide significant evidence of linkage for a candidate gene on
chromosome 16q22.
North American Indian childhood cirrhosis (NAIC; also
known as “CIRH1A” [MIM 604901]) is an isolated
nonsyndromic form of cholestasis found in Ojibway-
Cree children from First Nations communities in the
Abitibi region of northwestern Quebec, Canada (Weber
et al. 1981). The disease typically presents, in a child
who is otherwise well, with transient neonatal jaundice
that progresses to biliary cirrhosis requiring hepatic
transplantation in childhood or young adulthood. The
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biochemical and histopathologic features of the disease
suggest involvement of the bile ducts, rather than of the
bile canaliculi. They include elevated gamma glutamyl
transferase and alkaline phosphatase levels and, typi-
cally, marked fibrosis around portal bile ducts. Results
of imaging studies are not typical of known cholangio-
pathies, such as sclerosing cholangitis. Clinical and phys-
iological investigations to discover the underlying cause
of NAIC have been unsuccessful. Under the assumption
of autosomal recessive transmission and complete pen-
etrance, the carrier frequency in at-risk populations was
estimated to be ∼9% (E. Drouin, unpublished data). Hy-
pothesizing that a major founder mutation underlies
most or all cases of NAIC, we used a DNA-pooling
strategy to search for an excess of shared homozygosity
due to identity by descent (Sheffield et al. 1998) among
patients, compared with their unaffected first-degree
relatives.
Samples were obtained with ethics approval from the
Institutional Review Boards of Hoˆpital Sainte-Justine
Figure 1 Pedigrees of five families with NAIC. Blackened symbols represent individuals with clinically and biochemically documented NAIC. An asterisk (*) indicates an individual
whose DNA sample was genotyped. The identification prefix “N” denotes the initial 51 family members who provided DNA samples for the study; DNA samples from 7 additional NAIC
patients (designated “9038,” “9039,” “9052,” “9106,” “9108,” “9133,” and “9134”) became available later and were included in the linkage and haplotype analyses. The number in a
diamond-shaped symbol is the number of additional family members for whom DNA samples were not available.
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Figure 2 ABI 377 electropherograms for six SSLPs, for three DNA pools (parents, unaffected siblings, and patients). D15S657
and D7S1804 are representative markers that have multiple peaks in all DNA pools, corresponding to distinguishable alleles.GATA10G07
appears to be monomorphic in all three DNA pools. Three markers (D16S2624, D8S1106, and D4S403) had a predominant peak in
the DNA pool of affected children but differed by the presence of two or more peaks in the parent and unaffected-sibling pools.
and Montreal General Hospital. Of note, all known pa-
tients have been followed by A.R.-W. and/or E.D. Con-
senting individuals were visited by A.R.-W., E.D., and/
or G.A.M., who explained the study and obtained
written consent, pedigree information, and blood sam-
ples. The detailed clinical features of the patients in the
study will be described separately (E. Drouin, unpub-
lished data). Leukocyte DNA samples were obtained
from 13 affected individuals, as well as from their par-
ents and unaffected siblings, when available. These 51
individuals from five families are shown, with the iden-
tification prefix “N,” in figure 1. Three DNA pools were
used in the genomewide scan. The three DNA pools
contained equal quantities of DNA from the following
individuals: all available obligate heterozygote parents
( ), all 13 affected individuals with identificationN = 22
prefix “N,” and unaffected siblings (48, 46, 44, 45, 49,
39, 34, 5, 4, 17, 18, 24, 23, 27, 28, and 11). We limited
the number of subjects in the pool of unaffected siblings
to two individuals from each nuclear family, to avoid
overrepresentation of specific alleles. A genomewide
scan was performed with a set of 380 simple-sequence-
length polymorphisms (SSLPs). This marker panel is a
modified version of the Cooperative Human Linkage
Center Human Screening set version 6.0 (Dubovsky et
al. 1995) and includes selected Ge´ne´thon markers (Dib
et al. 1996). The three DNA pools were used as tem-
plates for DNA amplification. The DNA pool from af-
fected individuals was genotyped in duplicate. Each
marker was independently amplified using fluorescently
labeled primers (Life Technologies). The PCR products
were multiplexed and electrophoretically separated on
an ABI 377 DNA sequencer (PE Biosystems) using 5%
acrylamide gels. The gels were analyzed with GeneScan
version 2.0.2 peak-calling software (PE Biosystems) and
were inspected visually to identify markers with a pre-
dominant allele in the pools of affected individuals, com-
pared with the DNA pools of the parents and of unaf-
fected siblings. Genealogical data from an additional 79
individuals were used to construct the pedigrees (fig. 1).
All patients were of northern-Ojibway or Cree origin
and had both a history of neonatal jaundice and clinical
and biochemical evidence of a cholangiopathic process.
In all patients from whom liver samples were available,
the presence of biliary cirrhosis was confirmed. After the
initial mapping with pooled DNA, samples from small
archived liver samples from an additional seven patients
(designated “9038,” “9039,” “9052,” “9106,” “9108,”
“9133,” and “9134”) became available and were used
for further analysis.
After the genomewide scan, selected markers chosen
from the Center for Medical Genetics, Marshfield
Medical Research Foundation genetic map for chro-
mosomes 4, 8, and 16 were genotyped using individ-
ual DNA from the five NAIC pedigrees. Fluorescently
labeled oligonucleotides (Research Genetics) were used
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Table 1
LOD Scores for Linkage of NAIC and Chromosome 16 Markers
MARKER
GENETIC-MAP
POSITIONa
(cM)
LOD SCORE AT v =
.00 .01 .05 .10 .20 .30 .40
D16S3140 74.44  1.74 .40 .99 .96 .54 .15
D16S3089 80.00  .69 .67 1.05 .94 .54 .17
GATA138C05 81.15 1.41 1.48 1.52 1.37 .91 .46 .13
D16S514 81.15  .03 1.01 1.25 1.05 .63 .20
D16S3398 84.75  3.49 3.64 3.28 2.32 1.32 .44
D16S3067 85.94 4.44 4.34 3.85 3.24 1.97 .90 .13
D16S752 87.06 .81 .82 .81 .71 .46 .23 .06
D16S2624 87.62 4.04 3.91 3.40 2.80 1.72 .84 .24
D16S3025 88.18 2.58 2.52 2.31 2.03 1.47 .88 .31
D16S3106 88.18 .44 .45 .43 .37 .23 .11 .03
D16S512 89.63 1.20 1.41 1.76 1.77 1.34 .77 .25
D16S3083 92.10  2.17 .22 .43 .43 .22 .00
D16S3125 93.78  .91 1.98 2.06 1.54 .85 .24
D16S518 95.08  1.80 .59 .14 .10 .09 .03
a Map positions from the Center for Medical Genetics, Marshfield Medical Research
Foundation Web site.
for GATA138C05, D16S3398, D16S3067, D16S752,
D16S2624, D16S3025, and D16S518. ABI 377 gel files
were analyzed using an automated allele-calling software
package developed by Mark Daly atthe Whitehead In-
stitute/Massachusetts Institute of Technology Center
for Genome Research. For D16S3140, D16S3089,
D16S514, D16S3106, D16S512, D16S3083, and
D16S3125, the marker alleles were amplified by PCR
with one of the primers end-labeled with [32P]-gATP,
under standard conditions, and were analyzed as de-
scribed elsewhere (Richter et al. 1999).
Linkage between the NAIC locus and microsatellite
markers was analyzed using the FASTLINK software
package (version 4.1P [Cottingham et al. 1993; Scha¨ffer
et al. 1994; Scha¨ffer 1996; Becker et al. 1998]) of the
LINKAGE programs (version 5.2 [Lathrop and Lalouel
1984; Lathrop et al. 1984, 1986]). ILINK was used for
two-point linkage analysis assuming an autosomal re-
cessive trait with complete penetrance. The disease-allele
frequency was estimated to be .045. LOD scores were
computed from the likelihoods maximized over marker-
allele frequencies for selected values of recombination
fraction and at . (Terwilliger and Ott 1994;(v) ! .5 v = .5
Annunen et al. 1999). Genetic distances between micro-
satellite markers were obtained from the Center for
Medical Genetics, Marshfield Medical Research Foun-
dation Web site.
The DNA-pooling scheme allowed the genomewide
scan to be performed with ∼1,500 PCR reactions
( markers) loaded onto 14 ABI 377 gels. We4# 380
scored the ABI 377 trace data for 333 SSLPs, after dis-
carding 47 because of weak, absent, or incorrectly sized
PCR products. Three markers (D4S403, D8S1106, and
D16S2624) were potential candidates for close linkage
to the NAIC locus, since the affected DNA pools ap-
peared to contain a predominant allele, compared with
the control DNA pools (fig. 2).
Available family members were genotyped for
D4S403, D8S1106, and D16S2624. All affected indi-
viduals were homozygous for the same D16S2624 allele
(143 bp), whereas the marker was polymorphic in the
remaining family members. A LOD score of 4.04 at
was obtained for linkage of the NAIC locus andv = 0
D16S2624. A single D4S403 allele was present in 23 of
26 chromosomes from the patients. However, recom-
bination under the assumed genetic model was observed
between the NAIC locus and between NAIC and
D4S403 and D8S1106. There was little or no evidence
for linkage to D4S403 (and two distal markers) or to
D8S1106.
Thirteen additional chromosome 16 markers closely
linked to D16S2624 were genotyped. The maximum
LOD score was 4.44 at D16S3067 (table 1). The closest
recombinant flanking markers of the NAIC-associated
haplotype were D16S3398 and D16S3083, and these
define a 7.4-cM interval. Furthermore, all patients were
homozygous for a five-marker haplotype, composed of
D16S3067, D16S752, D16S2624, D16S3025, and
D16S3106 (table 2). The NAIC-associated haplotype is
flanked on the centromeric side by D16S3398 and on
the telomeric side by D16S512, an interval of 4.9 cM.
Two or more alleles of D16S3398 and D16S512 were
observed in the sample of NAIC chromosomes, sug-
gesting that ancestral recombination events occurred be-
tween these markers and the disease locus.
NAIC belongs to a heterogeneous group of autosomal
recessively inherited liver disorders characterized by an
early onset of cholestasis and progressing to cirrhosis
Table 2
Genotypes for Chromosome 16 Markers Observed in Patients with NAIC
PEDIGREE
AND ID
GENOTYPE FOR MARKERa
D16S3140
(74.44)
D16S3089
(80.00)
GATA138C05
(81.15)
D16S514
(81.15)
D16S3398
(84.75)
D16S3067
(85.94)b
D16S752
(87.06)b
D16S2624
(87.62)b
D16S3025
(88.18)b
D16S3106
(88.18)b
D16S512
(89.63)
D16S3083
(92.10)
D16S3125
(93.78)
D16S518
(95.08)
1:
N47 163/151 184/196 160 121/125 201 142 105 143 104 196 201/205 207 181 279/275
N62 167/151 184/196 160/143 121 201 142 105 143 104 196 201/207 200/212 203/207 283
N65 167/147 182/196 160/152 125 201 142 105 143 104 196 205 209/213 181/207 281/279
2:
N52 169/165 196 160 125 201 142 105 143 104 196 205 209 203 279
N53 169/165 196 160 125 201 142 105 143 104 196 205 209 203 279
9106 169/165 196 160 125 201 142 105 143 104 196 205 209 203 279
9108 165 196 160 125 201 142 105 143 104 196 205 209 203 279
3:
N25 165/151 190/194 160/155 121/125 201 142 105 143 104 196 201/207 207/213 203 283/273
N38 167/151 184/192 152 121 213/201 142 105 143 104 196 205/207 209/213 203/205 283/273
N54 165/151 184/192 152 121 213/201 142 105 143 104 196 205/207 209/213 203/205 283/273
9038 165/151 192/196 nd 121/125 201 142 105 143 104 196 201/207 199/207 203/205 273
9039 165/151 192/196 164/152 121/125 201 142 105 143 104 196 201/207 207/213 203 273/283
9052 … … … … … 142 105 143 104 196 … … … …
9133 … … … … … 142 105 143 104 nd … … … …
9134 167/165 186/196 160/152 121/125 213/201 142 105 143 104 196 201/205 207/209 203/205 273
5:
N10 151 192/194 152 121/125 201 142 105 143 104 196 201 213 183/195 281
N12 151 192/194 152 121/125 201 142 105 143 104 196 201 213 183/195 281/273
N13 169/151 184/194 152 125 201 142 105 143 104 196 201 213 183/195 281
6:
N56 169/167 184/196 143 125 201 142 105 143 104 196 207 213 203 283
N59 167/147 184/196 143 125 201 142 105 143 104 196 205/207 213 199/203 281/273
NOTE.—Each entry represents the two disease-associated haplotypes of the patient. Where the patient was homozygous for a marker locus, only the allele is given; otherwise
the heterozygous genotype is given.
a An ellipsis (…) denotes that the marker was not typed; nd = Genotype was not determined because it could not be reliably identified.
b Marker with identical alleles among all patients in the study.
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and often to liver failure before adulthood (Gray and
Saunders 1966; Toussaint and Gros 1966; Williams et
al. 1972). The clustering and segregation pattern of the
disease are consistent with a common ancestral mutation
causing the disease in all affected individuals. A founder
effect is consistent with the demographic history of Ca-
nadian Ojibway-Cree (McMillan 1995). Founder effect
has been observed, in other Native American popula-
tions, for autosomal recessive traits including type I glu-
taric acidemia (Haworth et al. 1991; Greenberg et al.
1995), pyruvate carboxylase deficiency (Robinson et al.
1984), and limb-girdle muscular dystrophy (Weiler et al.
1996) in Manitoba; for microcephaly-micromelia (Ives
and Houston 1980), hyperammonemia-hyperornithi-
nemia-homocitrullinuria syndrome (Camacho et al.
1999), and Sandhoff disease (Lowden et al. 1978) in
Saskatchewan; and, possibly, for an infantile leukoen-
cephalopathy in northern Manitoba and Quebec (Black
et al. 1988). In addition, founder effect has been sug-
gested for dominantly inherited conditions (Birt and Da-
vis 1975) and multigenic traits, such as type II diabetes
and hyperlipidemia (Hegele et al. 1998, 1999).
The multipoint LOD score of 4.44 provides strong
support for the location of the NAIC locus on distal
chromosome 16q. The observation of a haplotype
shared among all five families with NAIC is consistent
with the hypothesis that these individuals share the same
mutation, which is identical by descent. The 4.9-cM in-
terval defined by D16S3398 and D16S512 encompasses
the haplotype common to all NAIC-bearing chromo-
somes and is likely to contain the disease locus.
Clinically, NAIC has been suspected to be distinct
from previously described nonsyndromic familial cho-
lestases, because of its marked cholangiopathic features
and severe degree of fibrosis on liver histology. Three
such disorders, designated “progressive familial intra-
hepatic cholestases” (PFICs), are caused by mutations
in genes coding for canalicular transport proteins. In
PFIC-1, mutations in a P-type ATPase gene on chro-
mosome 18q21-q22 cause both Byler disease (Clayton
et al. 1969) and benign recurrent intrahepatic cholestasis
(Bull et al. 1998). PFIC-2 results from mutations in the
sister of the P-glycoprotein gene on chromosome 2q24,
which encodes a liver-specific ATP-binding cassette
transporter thought to be the human bile salt–export
pump (Strautnieks et al. 1998). PFIC-3 is caused by mu-
tations in the multidrug resistance–3 P glycoprotein gene
on chromosome 7q21 (de Vree et al. 1998). The present
study shows that NAIC is genetically distinct from the
three known PFICs. However, other familial infantile
cholestases have been reported in Greenland Inuit (Niel-
sen et al. 1986), Turks (Koc¸ak et al. 1997), and Arab
Israelis (Naveh et al. 1997). Available descriptions have
not permitted detailed clinical and pathological com-
parisons with NAIC. It is now possible to test these
patients for linkage to the NAIC locus. The mapping of
this locus is an important step toward understanding
this frequent and potentially fatal disease of First
Nations children in northwestern Quebec.
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